Skip to main content

Axsome Therapeutics, Inc.

AXSM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001579428

In the last 90 days, Axsome Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 505 institutions reported holding it in 13F filings for Q2 2026, worth $9.34B in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Axsome Therapeutics, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of AXSM: Q1 2024 compared with Q2 2024
MeasureQ1 2024Of which not filed for Q2 2024Q2 2024Change
Holders25922570
Shares38.8M43.9K40.7M+2.03M (+5.2%)
Value$3.09B$3.50M$3.28B+$189.9M (+6.1%)

2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (33)

Institutions that held Axsome Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to AXSM in Q2 2024
InstitutionSharesValue% of portfolio
BVF Inc955,000$76.9M2.15%
Cormorant Asset Management, LP400,000$32.2M1.87%
Sofinnova Investments, Inc.310,198$25.0M1.57%
Vestal Point Capital, LP300,000$24.1M1.80%
Scout Investments, Inc.69,558$5.60M0.15%
Standard Life Aberdeen plc39,675$3.19M0.01%
Assenagon Asset Management S.A.33,969$2.73M0.01%
Point72 Europe (London) LLP30,741$2.47M0.21%
Jump Financial, LLC27,119$2.18M0.04%
Meridian Wealth Management, LLC21,056$1.70M0.20%
Corebridge Financial, Inc.19,600$1.58M0.01%
Tudor Investment Corp Et Al18,983$1.53M0.02%
Mirae Asset Global ETFs Holdings Ltd.17,897$1.44M0.00%
Great Lakes Advisors, LLC12,141$977.4K0.01%
Quantitative Investment Management, LLC11,799$949.0K0.10%
Y-Intercept (Hong Kong) Ltd11,575$931.8K0.05%
Bank of Montreal10,531$848.9K0.00%
Nomura Holdings Inc9,077$730.7K0.00%
Aquatic Capital Management LLC5,200$418.6K0.02%
Axq Capital, LP4,892$393.8K0.09%
Brevan Howard Capital Management LP4,782$385.0K0.03%
Strategic Financial Concepts, LLC26,010$306.0K0.00%
Algert Global LLC3,105$250.0K0.01%
Flower City Capital3,000$241.5K0.16%
Point72 Asia (Singapore) Pte. Ltd.584$47.0K0.01%
Northwestern Mutual Wealth Management Co335$27.0K0.00%
ADAR1 Capital Management, LLC300$24.1K0.00%
Jones Financial Companies LLLP144$11.6K0.00%
Smartleaf Asset Management LLC55$4.40K0.00%
Ronald Blue Trust, Inc.48$3.83K0.00%
Meeder Asset Management Inc47$3.78K0.00%
Stephens Consulting, LLC20$1.61K0.00%
Parallel Advisors, LLC12$9660.00%

Sold out (33)

Institutions that held Axsome Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Not filed for Q2 2024 yet (2)

Institutions that held Axsome Therapeutics, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AXSM in Q1 2024 that haven't filed for Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Credit Suisse AG43,721$3.49M
Cutler Group LP200$15.0K